r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
A side-by-side editorial comparison of pharmaverseadam and ymlthis — release velocity, themes, recent moves, and the top alternatives to consider.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
ymlthis retired itself, naming Quarto as the reason it no longer needs to exist.
ymlthis built R Markdown YAML front matter programmatically — a fluent `yml_*()` interface plus RStudio add-ins, so users did not have to hand-write metadata blocks whose valid fields were scattered across output-format documentation. Version 1.0.0 declares the package retired, with only CRAN-preserving changes to follow, and states the reason plainly: Quarto now provides good YAML support.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
ymlthis built R Markdown YAML front matter programmatically — a fluent `yml_*()` interface plus RStudio add-ins, so users did not have to hand-write metadata blocks whose valid fields were scattered across output-format documentation. Version 1.0.0 declares the package retired, with only CRAN-preserving changes to follow, and states the reason plainly: Quarto now provides good YAML support.
The retirement is the endpoint of a long drift. Between 2020 and 2022 every release was reactive — patching around a crayon update that mangled rendered YAML, tracking shiny 1.6, following roxygen2 7.0.0, fixing a typo in an add-in. No new capability has landed in six years, and the four-year gap before 1.0.0 had already answered the question the release note finally makes explicit.
Nothing further of substance is expected — the stated policy is changes only where CRAN requires them, so the next release, if any, will be a compatibility patch.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaverseadam or ymlthis.
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul took mocking back from webmockr and made it a property of the client itself
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all pharmaverseadam alternatives → · See all ymlthis alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — r-language — within Analytics. pharmaverseadam and ymlthis are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. pharmaverseadam and ymlthis are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.
Top ymlthis alternatives in Analytics are ranked by recent ship velocity. Browse the "ymlthis alternatives" section above for the current picks, or visit /alternatives/ymlthis for the full list with editorial commentary on each.